Latest News

Friday, February 23, 2018

Lenstec and Oculentis Settle Legal Dispute Over Patents for Bifocal IOLs

Lenstec has stated that it has won its UK patent suit against Oculentis for bifocal IOLs. Oculentis has withdrawn legal proceedings against Lenstec in the UK High Court and made a payment towards Lens…

Read the full story

Friday, February 23, 2018

U.S. Vision Selects MaximEyes EHR by First Insight Corporation as its New EHR Partner for 600+ Locations

After an in-depth 2-year evaluation comparing various electronic health records (EHRs) used by optometrists, U.S. Vision and its affiliate, Nationwide Vision, selected MaximEyes EHR by First Insight C…

Read the full story

Friday, February 23, 2018

Allergy Drug May Reduce Relapse in Neuromyelitis Optica

The popular allergy medication cetirizine (Zyrtec, Johnson & Johnson Consumer Inc), when added to standard therapy, shows the potential to reduce the rate of relapse of the neuromyelitis optica (N…

Read the full story

Thursday, February 22, 2018

Apellis Pharmaceuticals Announces 18-Month Results of Phase 2 Study (FILLY) of APL-2 in Geographic Atrophy

Apellis Pharmaceuticals will provide an update with 18-month data on its phase 2 trial (FILLY) of its complement C3 inhibitor, APL-2, in patients with geographic atrophy (GA) associated with age-relat…

Read the full story

Thursday, February 22, 2018

Mistrial Declared After Jury Deadlocks in Insider Trading Case of James Mazzo

A federal judge in California declared a mistrial Wednesday in the alleged insider-trading scheme of James Mazzo after the jury deadlocked on whether Mr. Mazzo gave insider trading tips about his comp…

Read the full story

Thursday, February 22, 2018

Health Care Alliance for Patient Safety (ASP) Debuts to Advocate for ‘Patient Eye Health’

With support from the American Optometric Association (AOA) and two leading contact lens companies, the Health Care Alliance for Patient Safety (APS) made its public debut Wednesday and will “wo…

Read the full story

Wednesday, February 21, 2018

A Fake Organ Mimics What Happens in the Blink of an Eye

A new artificial organ gives a new meaning to the phrase “making eyes.” For the first time, researchers used human cells to build a model of the surface of the eye that’s equipped…

Read the full story

Wednesday, February 21, 2018

Anthem Says Eye Surgeons Should Monitor Cataract Anesthesia Themselves

If you need cataract surgery, your eye surgeon may have to do double duty as your anesthetist under a new policy by health insurer Anthem. In a clinical guideline released this month, the company says…

Read the full story

Wednesday, February 21, 2018

Eyenovia Advances MicroPine for Myopia Into Phase 3 Clinical Development

Eyenovia announced that following discussions with the FDA, it has received feedback on its pivotal trial protocol design, as well as confirmation to advance its MicroPine therapeutic program for the …

Read the full story

Tuesday, February 20, 2018

Therapeutic Target for Glaucoma Could Have Treatment Ramifications for Alzheimer’s and Parkinson’s

A therapeutic target to preserve vision in glaucoma patients could have treatment ramifications for age-related neurodegenerative disorders like Alzheimer's and Parkinson's, according to findi…

Read the full story

Tuesday, February 20, 2018

Study: Central Corneal Thickness Could Affect Glaucoma Risk

Research led by Emory Eye Center scientist Eldon E. Geisert, PhD, shows that a protein that affects corneal thickness might also be connected to glaucoma risk. The study, conducted on mice, found t…

Read the full story

Tuesday, February 20, 2018

World-Renowned Speakers Featured During the 2018 ASCRS•ASOA Annual Meeting General Sessions

The ASCRS Opening General Session -- Saturday, April 14 -- will note the 2018 Honored Guest Awardees: R. Bruce Wallace, MD, and Richard Packard, MD, DO, FRCS, FRCOphth. Dr. Wallace is the founder …

Read the full story

Tuesday, February 20, 2018

Second Sight Announces Market Entry into Singapore with First Implant of Argus II Retinal Prosthesis System

Second Sight Medical Products announced market entry into Singapore, with the first patient implanted with the Company’s Argus II Retinal Prosthesis System. The implantation was facilitated by t…

Read the full story

Tuesday, February 20, 2018

GenSight Biologics Announces Publication of Positive Data from Phase 1/2 Trial of GS010 for Leber Hereditary Optic Neuropathy

GenSight Biologics announced publication of detailed results from the phase 1/2 clinical trial and long-term follow-up of GS010 in Leber Hereditary Optic Neuropathy (LHON) patients in Ophthalmology. T…

Read the full story

Monday, February 19, 2018

Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles

The generic drug business has faced some struggles of recent amid that decline Swiss pharmaceutical company Novartis AG (NVS - Get Report) is reportedly gearing up to launch a sale process for its U.S…

Read the full story
Load More